After Oxford Covid vaccine dosing, trial participants to be given paracetamol ‘on SOS basis’

All 1,600 people who will participate in the trial for the Covid-19 vaccine candidate developed by the Oxford University will be given paracetamol after the vaccine dosage on an ‘SOS’ basis, The Print has learnt.

The Pune-based Serum Institute of India (SII) has partnered with Oxford University for the production of the vaccine candidate called Covishield, and will be spearheading these human trials.